RESEARCHER PROFILE

Wolf O. Bechstein

← Back to Goethe University Frankfurt

W

Goethe University Frankfurt

Organ Transplantation Techniques and OutcomesTransplantation: Methods and OutcomesHepatocellular Carcinoma Treatment and PrognosisRenal Transplantation Outcomes and TreatmentsColorectal Cancer Treatments and Studies

Wolf O. Bechstein works in Organ Transplantation Techniques and Outcomes, Transplantation: Methods and Outcomes, Hepatocellular Carcinoma Treatment and Prognosis, Renal Transplantation Outcomes and Treatments, Colorectal Cancer Treatments and Studies. Recorded institutional associations include Goethe University Frankfurt, University Hospital Frankfurt.

1,259Publications
35,913Citations
81H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

    2019 · 2,648 citations

  2. Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

    2007 · 2,419 citations

  3. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

    2008 · 1,937 citations

  4. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

    2013 · 1,306 citations

  5. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

    2009 · 963 citations

  6. Vascular Invasion and Histopathologic Grading Determine Outcome After Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis

    2001 · 894 citations

  7. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

    2016 · 743 citations

  8. Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

    2010 · 709 citations

  9. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

    2017 · 682 citations

  10. Extended Resections for Hilar Cholangiocarcinoma

    1999 · 675 citations

  11. Neurotoxicity of calcineurin inhibitors: impact and clinical management

    2000 · 578 citations

  12. Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

    2019 · 549 citations

  13. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer

    2017 · 487 citations

  14. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.

    1996 · 453 citations

  15. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)

    2012 · 442 citations

  16. Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma

    2015 · 433 citations

  17. The Role of Liver Transplantation in Hepatobiliary Malignancy. A Retrospective Analysis of 95 Patients with Particular Regard to Tumor Stage and Recurrence

    1989 · 372 citations

  18. Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

    2021 · 360 citations

  19. Randomized Trial of Surgery Versus Surgery Followed by Adjuvant Hepatic Arterial Infusion With 5-Fluorouracil and Folinic Acid for Liver Metastases of Colorectal Cancer

    1998 · 356 citations

  20. Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer

    2014 · 324 citations

  21. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients

    2017 · 315 citations

  22. CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

    2017 · 293 citations

  23. Toward a Consensus on Centralization in Surgery

    2018 · 270 citations

  24. Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)

    2014 · 264 citations

  25. Liver transplantation for Budd–Chiari syndrome: A European study on 248 patients from 51 centres

    2005 · 239 citations

← Return to the university profile